Clinical Monitoring Excellence: Driving Success Of Early-Phase Trials

Early‑phase clinical trials form the critical foundation of successful drug development, demanding precision, agility, and a high level of oversight. Led by Cate Hillock, Senior Director of Clinical Monitoring at Altasciences, this presentation explores how proactive, thoughtfully designed clinical monitoring strategies protect participant safety, strengthen site performance, and uphold data integrity in fast‑moving early‑phase studies, and is especially valuable for sponsors of early‑phase trials, clinical operations and project management teams, CRAs and lead CRAs, clinical site staff, and business development professionals.

By cultivating strong site relationships, leveraging the expertise of seasoned Clinical Research Associates, and fostering seamless collaboration across project teams, we’re able to anticipate challenges early and resolve them efficiently. Watch the video below to gain insight into the core elements that make clinical monitoring truly effective — from risk‑based oversight approaches to clear, timely communication — and see how a cohesive, experienced team drives both quality and operational excellence. The session also highlights how monitoring teams act as an extension of the sponsor, the essential role of site engagement, the specialized skills required for monitoring success, and how excellence in these areas directly translates into real‑world trial performance.